1h Free Analyst Time
The cancer supportive care market is forecasted to grow by $6,563.92 mn during 2022-2027, accelerating at a CAGR of 4.62% during the forecast period. The report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with the cancer treatment, and untapped potential in developing countries.
The cancer supportive care market is segmented as below:
By Distribution Channel
- Hospitals pharmacies
- Drug stores and retail pharmacies
- Online providers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cancer supportive care market covers the following areas:
- Cancer supportive care market sizing
- Cancer supportive care market forecast
- Cancer supportive care market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global cancer supportive care market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global cancer supportive care market 2017 - 2021 ($ million)
4.2 Therapeutic area Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapeutic area Segment 2017 - 2021 ($ million)
4.3 Distribution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Therapeutic Area
6.1 Market segments
Exhibit 30: Chart on Therapeutic Area - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapeutic Area - Market share 2022-2027 (%)
6.2 Comparison by Therapeutic Area
Exhibit 32: Chart on Comparison by Therapeutic Area
Exhibit 33: Data Table on Comparison by Therapeutic Area
6.3 Chemotherapy-induced anemia - Market size and forecast 2022-2027
Exhibit 34: Chart on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
6.4 Chemotherapy-induced neutropenia - Market size and forecast 2022-2027
Exhibit 38: Chart on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
6.5 Cancer pain - Market size and forecast 2022-2027
Exhibit 42: Chart on Cancer pain - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Cancer pain - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Cancer pain - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Cancer pain - Year-over-year growth 2022-2027 (%)
6.6 CINV - Market size and forecast 2022-2027
Exhibit 46: Chart on CINV - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on CINV - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on CINV - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on CINV - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Therapeutic Area
Exhibit 54: Market opportunity by Therapeutic Area ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 57: Chart on Comparison by Distribution Channel
Exhibit 58: Data Table on Comparison by Distribution Channel
7.3 Hospitals pharmacies - Market size and forecast 2022-2027
Exhibit 59: Chart on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Drug stores and retail pharmacies - Market size and forecast 2022-2027
Exhibit 63: Chart on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Online providers - Market size and forecast 2022-2027
Exhibit 67: Chart on Online providers - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Online providers - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Online providers - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Online providers - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 71: Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 75: Chart on Geographic comparison
Exhibit 76: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 111: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 113: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 114: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 116: Overview on factors of disruption
11.4 Industry risks
Exhibit 117: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 118: Vendors covered
12.2 Market positioning of vendors
Exhibit 119: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 120: Amgen Inc. - Overview
Exhibit 121: Amgen Inc. - Product / Service
Exhibit 122: Amgen Inc. - Key offerings
12.4 Baxter International Inc.
Exhibit 123: Baxter International Inc. - Overview
Exhibit 124: Baxter International Inc. - Business segments
Exhibit 125: Baxter International Inc. - Key news
Exhibit 126: Baxter International Inc. - Key offerings
Exhibit 127: Baxter International Inc. - Segment focus
12.5 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.6 Daiichi Sankyo Co. Ltd.
Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 134: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 137: Daiichi Sankyo Co. Ltd. - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 143: GlaxoSmithKline Plc - Overview
Exhibit 144: GlaxoSmithKline Plc - Business segments
Exhibit 145: GlaxoSmithKline Plc - Key offerings
Exhibit 146: GlaxoSmithKline Plc - Segment focus
12.9 Heron Therapeutics Inc.
Exhibit 147: Heron Therapeutics Inc. - Overview
Exhibit 148: Heron Therapeutics Inc. - Product / Service
Exhibit 149: Heron Therapeutics Inc. - Key news
Exhibit 150: Heron Therapeutics Inc. - Key offerings
12.10 Johnson and Johnson
Exhibit 151: Johnson and Johnson - Overview
Exhibit 152: Johnson and Johnson - Business segments
Exhibit 153: Johnson and Johnson - Key news
Exhibit 154: Johnson and Johnson - Key offerings
Exhibit 155: Johnson and Johnson - Segment focus
12.11 Kyowa Kirin Co. Ltd.
Exhibit 156: Kyowa Kirin Co. Ltd. - Overview
Exhibit 157: Kyowa Kirin Co. Ltd. - Product / Service
Exhibit 158: Kyowa Kirin Co. Ltd. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 159: Merck and Co. Inc. - Overview
Exhibit 160: Merck and Co. Inc. - Business segments
Exhibit 161: Merck and Co. Inc. - Key news
Exhibit 162: Merck and Co. Inc. - Key offerings
Exhibit 163: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 164: Novartis AG - Overview
Exhibit 165: Novartis AG - Business segments
Exhibit 166: Novartis AG - Key offerings
Exhibit 167: Novartis AG - Segment focus
12.14 Purdue Pharma LP
Exhibit 168: Purdue Pharma LP - Overview
Exhibit 169: Purdue Pharma LP - Product / Service
Exhibit 170: Purdue Pharma LP - Key offerings
12.15 Sanofi SA
Exhibit 171: Sanofi SA - Overview
Exhibit 172: Sanofi SA - Business segments
Exhibit 173: Sanofi SA - Key news
Exhibit 174: Sanofi SA - Key offerings
Exhibit 175: Sanofi SA - Segment focus
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 176: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 177: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 178: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 179: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 183: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 186: Currency conversion rates for US$
13.4 Research methodology
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
13.5 List of abbreviations
Exhibit 190: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global cancer supportive care market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Therapeutic area Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Therapeutic Area - Market share 2022-2027 (%)
Exhibits 31: Data Table on Therapeutic Area - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Therapeutic Area
Exhibits 33: Data Table on Comparison by Therapeutic Area
Exhibits 34: Chart on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Cancer pain - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Cancer pain - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Cancer pain - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Cancer pain - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on CINV - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on CINV - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on CINV - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on CINV - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Therapeutic Area ($ million)
Exhibits 55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 57: Chart on Comparison by Distribution Channel
Exhibits 58: Data Table on Comparison by Distribution Channel
Exhibits 59: Chart on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 63: Chart on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Online providers - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Online providers - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Online providers - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Online providers - Year-over-year growth 2022-2027 (%)
Exhibits 71: Market opportunity by Distribution Channel ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 111: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 113: Market opportunity By Geographical Landscape ($ million)
Exhibits 114: Impact of drivers and challenges in 2022 and 2027
Exhibits 115: Overview on Criticality of inputs and Factors of differentiation
Exhibits 116: Overview on factors of disruption
Exhibits 117: Impact of key risks on business
Exhibits 118: Vendors covered
Exhibits 119: Matrix on vendor position and classification
Exhibits 120: Amgen Inc. - Overview
Exhibits 121: Amgen Inc. - Product / Service
Exhibits 122: Amgen Inc. - Key offerings
Exhibits 123: Baxter International Inc. - Overview
Exhibits 124: Baxter International Inc. - Business segments
Exhibits 125: Baxter International Inc. - Key news
Exhibits 126: Baxter International Inc. - Key offerings
Exhibits 127: Baxter International Inc. - Segment focus
Exhibits 128: Bayer AG - Overview
Exhibits 129: Bayer AG - Business segments
Exhibits 130: Bayer AG - Key news
Exhibits 131: Bayer AG - Key offerings
Exhibits 132: Bayer AG - Segment focus
Exhibits 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 134: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 136: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 137: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits 138: F. Hoffmann La Roche Ltd. - Overview
Exhibits 139: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 140: F. Hoffmann La Roche Ltd. - Key news
Exhibits 141: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 142: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 143: GlaxoSmithKline Plc - Overview
Exhibits 144: GlaxoSmithKline Plc - Business segments
Exhibits 145: GlaxoSmithKline Plc - Key offerings
Exhibits 146: GlaxoSmithKline Plc - Segment focus
Exhibits 147: Heron Therapeutics Inc. - Overview
Exhibits 148: Heron Therapeutics Inc. - Product / Service
Exhibits 149: Heron Therapeutics Inc. - Key news
Exhibits 150: Heron Therapeutics Inc. - Key offerings
Exhibits 151: Johnson and Johnson - Overview
Exhibits 152: Johnson and Johnson - Business segments
Exhibits 153: Johnson and Johnson - Key news
Exhibits 154: Johnson and Johnson - Key offerings
Exhibits 155: Johnson and Johnson - Segment focus
Exhibits 156: Kyowa Kirin Co. Ltd. - Overview
Exhibits 157: Kyowa Kirin Co. Ltd. - Product / Service
Exhibits 158: Kyowa Kirin Co. Ltd. - Key offerings
Exhibits 159: Merck and Co. Inc. - Overview
Exhibits 160: Merck and Co. Inc. - Business segments
Exhibits 161: Merck and Co. Inc. - Key news
Exhibits 162: Merck and Co. Inc. - Key offerings
Exhibits 163: Merck and Co. Inc. - Segment focus
Exhibits 164: Novartis AG - Overview
Exhibits 165: Novartis AG - Business segments
Exhibits 166: Novartis AG - Key offerings
Exhibits 167: Novartis AG - Segment focus
Exhibits 168: Purdue Pharma LP - Overview
Exhibits 169: Purdue Pharma LP - Product / Service
Exhibits 170: Purdue Pharma LP - Key offerings
Exhibits 171: Sanofi SA - Overview
Exhibits 172: Sanofi SA - Business segments
Exhibits 173: Sanofi SA - Key news
Exhibits 174: Sanofi SA - Key offerings
Exhibits 175: Sanofi SA - Segment focus
Exhibits 176: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 177: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 178: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 179: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 180: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 181: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 182: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 183: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 184: Inclusions checklist
Exhibits 185: Exclusions checklist
Exhibits 186: Currency conversion rates for US$
Exhibits 187: Research methodology
Exhibits 188: Validation techniques employed for market sizing
Exhibits 189: Information sources
Exhibits 190: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global cancer supportive care market: Acacia Pharma Group Plc, Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the advent of biosimilars in cancer-associated treatment.`
According to the report, one of the major drivers for this market is the growing prevalence of cancer cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acacia Pharma Group Plc
- Amgen Inc.
- Baxter International Inc.
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Helsinn Healthcare SA
- Heron Therapeutics Inc.
- Johnson and Johnson
- Kyowa Kirin Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Purdue Pharma LP
- RELIEF THERAPEUTICS Holding SA
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
